These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18212750)

  • 21. Leptin induces CYP1B1 expression in MCF-7 cells through ligand-independent activation of the ERα pathway.
    Khanal T; Kim HG; Do MT; Choi JH; Won SS; Kang W; Chung YC; Jeong TC; Jeong HG
    Toxicol Appl Pharmacol; 2014 May; 277(1):39-48. PubMed ID: 24631339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of several dioxin-like compounds on estrogen metabolism in the malignant MCF-7 and nontumorigenic MCF-10A human mammary epithelial cell lines.
    van Duursen MB; Sanderson JT; van der Bruggen M; van der Linden J; van den Berg M
    Toxicol Appl Pharmacol; 2003 Aug; 190(3):241-50. PubMed ID: 12902195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of CYP1A1, CYP1A2, and CYP1B1 mRNAs by nitropolycyclic aromatic hydrocarbons in various human tissue-derived cells: chemical-, cytochrome P450 isoform-, and cell-specific differences.
    Iwanari M; Nakajima M; Kizu R; Hayakawa K; Yokoi T
    Arch Toxicol; 2002 Jun; 76(5-6):287-98. PubMed ID: 12107646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway.
    Zhang X; Zhong S; Xu Y; Yu D; Ma T; Chen L; Zhao Y; Chen X; Yang S; Wu Y; Tang J; Zhao J
    PLoS One; 2016; 11(4):e0153194. PubMed ID: 27045586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin E2 induces CYP1B1 expression via ligand-independent activation of the ERalpha pathway in human breast cancer cells.
    Han EH; Kim HG; Hwang YP; Song GY; Jeong HG
    Toxicol Sci; 2010 Apr; 114(2):204-16. PubMed ID: 20093341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate apoptosis response-4 is involved in the apoptosis response to docetaxel in MCF-7 breast cancer cells.
    Pereira MC; de Bessa-Garcia SA; Burikhanov R; Pavanelli AC; Antunes L; Rangnekar VM; Nagai MA
    Int J Oncol; 2013 Aug; 43(2):531-8. PubMed ID: 23760770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1,25-Dihydroxyvitamin D3 inhibits growth of the breast cancer cell line MCF-7 and downregulates cytochrome P4501B1 through the COX-2/PGE2 pathway.
    Yuan L; Jiang R; Yang Y; Ding S; Deng H
    Oncol Rep; 2012 Dec; 28(6):2131-7. PubMed ID: 22971613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of carcinogen-activating enzymes by 16alpha-fluoro-5-androsten-17-one.
    Ciolino HP; MacDonald CJ; Yeh GC
    Cancer Res; 2002 Jul; 62(13):3685-90. PubMed ID: 12097275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytochrome P450 1B1 gene polymorphisms as predictors of anticancer drug activity: studies with in vitro models.
    Laroche-Clary A; Le Morvan V; Yamori T; Robert J
    Mol Cancer Ther; 2010 Dec; 9(12):3315-21. PubMed ID: 20889730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of human cytochrome P450 1B1 expression by 2,4,3',5'-tetramethoxystilbene.
    Chun YJ; Lee SK; Kim MY
    Drug Metab Dispos; 2005 Dec; 33(12):1771-6. PubMed ID: 16120791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells.
    Hansen SN; Ehlers NS; Zhu S; Thomsen MB; Nielsen RL; Liu D; Wang G; Hou Y; Zhang X; Xu X; Bolund L; Yang H; Wang J; Moreira J; Ditzel HJ; Brünner N; Schrohl AS; Stenvang J; Gupta R
    BMC Genomics; 2016 Jun; 17():442. PubMed ID: 27277198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential regulation of cytochrome P450 1A1 and 1B1 by a combination of dioxin and pesticides in the breast tumor cell line MCF-7.
    Coumoul X; Diry M; Robillot C; Barouki R
    Cancer Res; 2001 May; 61(10):3942-8. PubMed ID: 11358810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.
    Zhong S; Li W; Chen Z; Xu J; Zhao J
    Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypermethylation of the ABCB1 downstream gene promoter accompanies ABCB1 gene amplification and increased expression in docetaxel-resistant MCF-7 breast tumor cells.
    Reed K; Hembruff SL; Laberge ML; Villeneuve DJ; Côté GB; Parissenti AM
    Epigenetics; 2008 Sep; 3(5):270-80. PubMed ID: 19001875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different response of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB 231 cells.
    Döhr O; Vogel C; Abel J
    Arch Biochem Biophys; 1995 Aug; 321(2):405-12. PubMed ID: 7646066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preferential induction of CYP1A1 over CYP1B1 in human breast cancer MCF-7 cells after exposure to berberine.
    Wen CJ; Wu LX; Fu LJ; Shen DY; Zhang X; Zhang YW; Yu J; Zhou HH
    Asian Pac J Cancer Prev; 2014; 15(1):495-9. PubMed ID: 24528081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of human cytochrome p450 1b1 further clarifies its role in the activation of dibenzo[a,l]pyrene in cells in culture.
    Mahadevan B; Luch A; Atkin J; Haynes M; Nguyen T; Baird WM
    J Biochem Mol Toxicol; 2007; 21(3):101-9. PubMed ID: 17623886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 12-O-tetradecanoylphorbol-13-acetate upregulates the Ah receptor and differentially alters CYP1B1 and CYP1A1 expression in MCF-7 breast cancer cells.
    Spink BC; Fasco MJ; Gierthy JF; Spink DC
    J Cell Biochem; 1998 Sep; 70(3):289-96. PubMed ID: 9706865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines.
    Li WJ; Zhong SL; Wu YJ; Xu WD; Xu JJ; Tang JH; Zhao JH
    Mol Biol Rep; 2013 Nov; 40(11):6143-50. PubMed ID: 24078162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.